First Financial Nort (FFNW) 13.28 $FFNW First Financial

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Financial Nort (FFNW) 13.28 $FFNW

First Financial Northwest, Inc. Announces Final Results of Its Self-Tender Offer
GlobeNewswire - Mon Aug 15, 3:05PM CDT
First Financial Northwest, Inc. (NASDAQ:FFNW) ("First Financial" or the "Company" announced today the final results of its modified Dutch Auction tender offer, which expired at 12:00 midnight, New York City time, on Tuesday, August 9, 2016.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Announces Preliminary Results of Self-Tender Offer
GlobeNewswire - Wed Aug 10, 5:00AM CDT
First Financial Northwest, Inc. (NASDAQ:FFNW) ("First Financial" or the "Company" announced today the preliminary results of its modified Dutch Auction tender offer, which expired at 12:00 midnight, New York City time, on August 9, 2016.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Announces Quarterly Cash Dividend of $0.06 per Share
GlobeNewswire - Thu Jul 28, 8:15AM CDT
First Financial Northwest, Inc. (the "Company" (NASDAQ:FFNW), the holding company for First Financial Northwest Bank ("Bank", today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share on the Company's outstanding common stock. The cash dividend will be payable on September 23, 2016, to shareholders of record as of the close of business on September 9, 2016.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Announces - First Financial Northwest Bank and Renton High School Renew Partnership to Teach Football Team Financial Literacy
GlobeNewswire - Fri Jun 03, 8:15AM CDT
First Financial Northwest, Inc. ("Company" (NASDAQ:FFNW) today announced that its subsidiary financial institution, First Financial Northwest Bank (FFNWB) has renewed its partnership with the Renton High School (RHS) Football Program to provide financial literacy skills to students in the community by utilizing a highly original and successful teaching method that was developed through this partnership last year.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Announces - First Financial Northwest Bank Receives the Innovation in Financial Education Award
GlobeNewswire - Thu Jun 02, 8:30AM CDT
First Financial Northwest, Inc. ("Company" (NASDAQ:FFNW) today announced that its subsidiary financial institution, First Financial Northwest Bank (FFNWB), a leading community bank with a 93-year history of serving the needs of our customers, is pleased to announce new contributions to the communities we serve. At First Financial, lending money is only one way we serve our communities; we also support many local organizations with donations of our resources and time, including the funding of projects within our communities.
FFNW: 13.28 (+0.17)

First Financial posts 1Q profit
Automated Insights - Thu Apr 28, 9:12AM CDT
RENTON, Wash. (AP) _ First Financial Northwest Inc. (FFNW) on Thursday reported first-quarter net income of $1.8 million.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Reports First Quarter Net Income of $1.8 Million or $0.14 per Diluted Share
GlobeNewswire - Thu Apr 28, 8:15AM CDT
First Financial Northwest, Inc. (the "Company" (NASDAQ:FFNW), the holding company for First Financial Northwest Bank (the "Bank", today reported net income for the quarter ended March 31, 2016, of $1.8 million, or $0.14 per diluted share, compared to net income of $2.1 million, or $0.16 per diluted share, for the quarter ended December 31, 2015, and $2.2 million, or $0.16 per diluted share, for the quarter ended March 31, 2015.
FFNW: 13.28 (+0.17)

First Financial Northwest Has Returned 67.9% Since SmarTrend Recommendation (FFNW)
Comtex SmarTrend(R) - Thu Feb 04, 3:35PM CST
SmarTrend identified an Uptrend for First Financial Northwest (NASDAQ:FFNW) on January 3rd, 2013 at $7.89. In approximately 38 months, First Financial Northwest has returned 67.93% as of today's recent price of $13.25.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Announces Completion of Charter Change of Subsidiary Bank
GlobeNewswire - Thu Feb 04, 10:04AM CST
First Financial Northwest, Inc. ("Company" (NASDAQ:FFNW), the bank holding company for First Financial Northwest Bank ("Bank", today announced that the Bank has completed its previously announced change in its charter from a Washington chartered stock savings bank to a Washington chartered commercial bank effective February 4, 2016. The Bank will continue to use its current corporate title as a commercial bank. The charter conversion was approved by the Washington Department of Financial Institutions on January 14, 2016.
FISI: 26.90 (+0.02), FFNW: 13.28 (+0.17)

First Financial Northwest Has Returned 71.2% Since SmarTrend Recommendation (FFNW)
Comtex SmarTrend(R) - Thu Jan 28, 10:28AM CST
SmarTrend identified an Uptrend for First Financial Northwest (NASDAQ:FFNW) on January 3rd, 2013 at $7.89. In approximately 37 months, First Financial Northwest has returned 71.23% as of today's recent price of $13.51.
FFNW: 13.28 (+0.17)

First Financial Northwest, Inc. Reports Fourth Quarter Net Income of $2.1 Million or $0.16 Per Diluted Share and $9.2 Million or $0.67 Per Diluted Share for the Year Ended December 31, 2015
GlobeNewswire - Thu Jan 28, 8:15AM CST
First Financial Northwest, Inc. (the "Company" (NASDAQ:FFNW), the holding company for First Financial Northwest Bank (the "Bank", today reported net income for the quarter ended December 31, 2015, of $2.1 million, or $0.16 per diluted share, compared to net income of $2.4 million, or $0.18 per diluted share, for the quarter ended September 30, 2015, and $2.9 million, or $0.20 per diluted share, for the fourth quarter in 2014. For the year ended December 31, 2015, net income was $9.2 million or $0.67 per diluted share, compared to $10.7 million or $0.71 per diluted share for the year ended December 31, 2014.
FFNW: 13.28 (+0.17)

First Financial Northwest Shares Up 70.6% Since SmarTrend's Buy Recommendation (FFNW)
Comtex SmarTrend(R) - Wed Jan 20, 9:34PM CST
SmarTrend identified an Uptrend for First Financial Northwest (NASDAQ:FFNW) on January 3rd, 2013 at $7.89. In approximately 37 months, First Financial Northwest has returned 70.60% as of today's recent price of $13.46.
FFNW: 13.28 (+0.17)

Uptrend Call Working As First Financial Northwest Stock Rises 70.3% (FFNW)
Comtex SmarTrend(R) - Wed Jan 06, 10:29AM CST
SmarTrend identified an Uptrend for First Financial Northwest (NASDAQ:FFNW) on January 3rd, 2013 at $7.89. In approximately 37 months, First Financial Northwest has returned 70.34% as of today's recent price of $13.44.
FFNW: 13.28 (+0.17)

77.4% Return Seen to Date on SmarTrend First Financial Northwest Call (FFNW)
Comtex SmarTrend(R) - Wed Dec 30, 9:17AM CST
SmarTrend identified an Uptrend for First Financial Northwest (NASDAQ:FFNW) on January 3rd, 2013 at $7.89. In approximately 36 months, First Financial Northwest has returned 77.44% as of today's recent price of $14.00.
FFNW: 13.28 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading